This study was conducted to assess the bioequivalence of the ezetimibe tablet to Ezetrol ® in healthy Chinese volunteers and estimate the pharmacokinetic profiles of ezetimibe tablet.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
59
The subjects randomly received single oral administration of ezetimibe tablet 10 mg
The subjects randomly received single oral administration of ezetimibe tablet (Ezetrol ®) 10 mg.
Clinical Research Center
Qingdao, Shandong, China
Peak Plasma Concentration (Cmax) Peak Plasma Concentration (Cmax)
Peak Plasma Concentration (Cmax) Evaluation of Peak Plasma Concentration (Cmax)
Time frame: 80 days
Area under the plasma concentration versus time curve (AUC)0-t
Evaluation of Area under the plasma concentration versus time curve (AUC)0-t
Time frame: 80 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.